Gene therapy may protect normal tissues during radiation retreatment for lung cancer
Gene therapy could be used as an agent to protect normal tissues, including the esophagus and lung, from damage during a second administration of radiation therapy for non-small cell lung cancer, according to an animal study presented today by University of Pittsburgh researchers at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver.
"A major challenge in treating lung tumors with radiation is the toxicity of radiation to healthy tissue," said Joel S. Greenberger, M.D., professor, University of Pittsburgh School of Medicine. "This can result in major quality-of-life issues for lung cancer patients receiving radiation therapy for their diseases. In previous studies, we demonstrated that gene therapy may protect healthy tissues from damage prior to an initial course of radiation therapy. In this study, we found that gene therapy also can protect the same healthy tissue during retreatment with radiation." Dr. Greenberger explained that a related study shows the effectiveness of aerosol delivery of this therapy by an inhalation nebulizer making it clinically feasible.
In the study, animal models were used to test the protective effects of manganese superoxide dismutase plasmid liposome (MnSOD-PL) gene therapy during exposure to radiation. One group of mice received an intratracheal injection of MnSOD-PL 24 hours before a course of 14 Gy irradiation, while a second group received 14 Gy irradiation alone. The mice were observed for six months for any toxic pulmonary effects and then subdivided into two more groups. One of these groups was exposed to a second lung irradiation of 10 Gy without MnSOD-PL and the other received an injection of MnSOD-PL 24 hours prior to radiation exposure.
The researchers found that in mice that received the initial 14 Gy dose there was 50 percent survival at 180 days (due to lung toxicity) compared to 87.5 percent survival during the same length of time for mice that were injected with MnSOD-PL prior to irradiation. Mice that received MnSOD-PL before both the 14 Gy dose as well as the subsequent 10 Gy dose had the best survival rate overall. Mice treated with MnSOD-PL before the first dose of radiation had a survival rate of 31.6 percent, while mice receiving the treatment before both courses of radiation had a survival rate of 47.6 percent.
"Administration of this type of gene therapy appeared to prevent the damaging effects of radiation, even when the radiation was re-administered after six months," said Dr. Greenberger. "Future studies will tell us whether this therapy can improve the quality of life for lung cancer patients and help us more effectively treat lung cancer without the damaging side effects."
Lung cancer is the leading cause of cancer-related death in men and women. In 2005, more than 170,000 new cases of lung cancer will be diagnosed. Side effects from radiation therapy for lung cancer can include fatigue, skin changes, swelling of the esophagus, hair loss in the treated area, dry cough caused by swelling of the lung tissue and sore throat.
Clare Collins | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.
Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...